{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:09:00Z","timestamp":1762542540638,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.brachy.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T10:22:09Z","timestamp":1463048529000},"page":"420-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Nicola J.","family":"Nasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil'ad N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence T.","family":"Dauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2016.03.012_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.brachy.2014.01.007","article-title":"Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy","volume":"13","author":"Nasser","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1\u2013T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bju.12514","article-title":"Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer","volume":"114","author":"Spratt","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.brachy.2015.09.004","article-title":"Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer","volume":"14","author":"Xiang","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.brachy.2015.03.004","article-title":"Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer","volume":"14","author":"Muralidhar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2014.06.008","article-title":"Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients","volume":"14","author":"Yorozu","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brachy.2014.08.044","article-title":"Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer","volume":"14","author":"Nasser","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.03.012_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brachy.2006.11.001","article-title":"American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103","volume":"6","author":"Rivard","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib12","first-page":"1","article-title":"Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources","volume":"35","year":"2005","journal-title":"Ann ICRP"},{"key":"10.1016\/j.brachy.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2004.02.002","article-title":"Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy","volume":"3","author":"Dauer","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brachy.2009.06.006","article-title":"Less-restrictive, patient-specific radiation safety precautions can be safely prescribed after permanent seed implantation","volume":"9","author":"Dauer","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0360-3016(02)04142-1","article-title":"Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy","volume":"55","author":"Zelefsky","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.03.012_bib19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1088\/0031-9155\/48\/9\/306","article-title":"Intraoperative dynamic dosimetry for prostate implants","volume":"48","author":"Todor","year":"2003","journal-title":"Phys Med Biol"},{"year":"2005","series-title":"Consolidated guidance about materials licences. Program specific guidance about medical use licenses. Final report","key":"10.1016\/j.brachy.2016.03.012_bib20"},{"year":"2006","series-title":"Management of radionuclide therapy patients","key":"10.1016\/j.brachy.2016.03.012_bib21"},{"key":"10.1016\/j.brachy.2016.03.012_bib22","first-page":"1","article-title":"The 2007 recommendations of the International Commission on Radiological Protection. Icrp publication 103","volume":"37","year":"2007","journal-title":"Ann ICRP"},{"year":"2006","series-title":"Same-sex couples and the gay, lesbian, bisexual population: new estimates from the American Community Survey","author":"Gates","key":"10.1016\/j.brachy.2016.03.012_bib23"},{"key":"10.1016\/j.brachy.2016.03.012_bib24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0360-3016(02)03030-4","article-title":"Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma","volume":"54","author":"Robinson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.03.012_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2003.09.015","article-title":"Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A review","volume":"45","author":"Henderson","year":"2004","journal-title":"Eur Urol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116300198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116300198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:10:00Z","timestamp":1761531000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472116300198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1538472116300198"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2016.03.012","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}